Evaluation of the efficacy of a full-spectrum medicinal cannabis plant extract with less than 0.3% Delta9-tetrahydrocannabinol in in vitro models of inflammation and excitotoxicity
E. Ross-Munro, E. Isikgel, B. Fleiss
This study evaluates NTI-164, a full-spectrum cannabis extract with low THC, showing enhanced anti-inflammatory and neuroprotective effects compared to CBD alone in vitro.
bioRxiv · Jan 10, 2024 · PreprintCell Biology